Synapticure, a telemedicine company focused on people and caregivers living with neurodegenerative diseases, announced it has raised $25 million in a Series A funding round led by B Capital.
New investors CVS Health Ventures, RA Capital Management, CommonSpirit Health and Nexus NeuroTech Ventures participated in the round, with participation from existing investors Google Ventures, Rock Health...
Synapticure, a telemedicine company focused on people and caregivers living with neurodegenerative diseases, announced it is partnering with Pearl Health, a technology company centered on physician enablement in value-based care, to provide personalized support to Medicare patients with dementia.
The collaboration aims to benefit dementia patients and their families through the CMS GUIDE (Guiding...
Synapticure, a telemedicine company focused on neurodegenerative disease, announced it is partnering with the ALS Association to offer Synapticure’s telehealth platform as a supplement to in-person care at ALS Certified Treatment Centers of Excellence and Recognized Treatment Centers.
Synapticure is a neurology-focused telehealth company that specializes in neurodegenerative diseases. It provides...
